Companies · Software / Tech

Axonics Modulation Technologies, Inc.

IRVINE · Software / Tech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Axonics Modulation Technologies, Inc. — recommendation, valuation, rhythm, risks.
$124.4M
Total raised · real
4
Rounds
0.3×
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Fri Apr 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Axonics Modulation Technologies, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.10× the median modeled value of Series C Software / Tech companies in 2016–2018 (22 peers) — value vs value, same stage and era.
  • Within the normal band (110% of peer median) for its niche.
Dormant
  • Last raise 9.2 yr ago; this sector typically re-raises about every 13 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Software / Tech

Axonics Modulation Technologies, Inc. is one of 3920 Software / Tech companies tracked from IRVINE. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
11
Investors (latest)
2017-04-28
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries A · 2014-03-14 Raised $14M (real) Modeled valuation $374M (est)$14M$374MSeries A2014Series B · 2015-04-15 Raised $17M (real) Modeled valuation $526M (est)$17M$526MSeries B2015Series B · 2015-12-04 Raised $39M (real) Modeled valuation $1.2B (est)$39M$1.2BSeries B2015Series C · 2017-04-28 Raised $55M (real) Modeled valuation $1.7B (est)$55M$1.7BSeries C2017Series A · 2017-04-28 Raised $14M (real) Modeled valuation $401M (est)$14M$401MSeries A2017+$17M+$39M+$55M+$14MCumulative $139M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$13.5M · 2014
Series B$17.3M · 2015
Series B extension$38.5M · 2015
Series C$55.1M · 2017
Bridge · Series C-stage$14.5M · 2017smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$1.7B
Base estimate est.
$208.8M
Conservative case
$4.6B
Upside case
$367.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.

Series A · modeled $374.5M · 2014-03-142014Series B · modeled $526.3M · 2015-04-15Series B · modeled $1.2B · 2015-12-04Series C · modeled $1.7B · 2017-04-28Series A · modeled $401.0M · 2017-04-282017
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
76%
Survival probability
57% low · 88% high
1.35×/yr
Annual markup
1.55×/yr upside case
6.0 yr
Elapsed time used
9.2 yr actual, capped for stale marks
technology
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
9 mo
Avg between rounds
$39.8M/yr
Capital velocity
12.3 yr
On record since
2014
First round
5
Rounds on file
How it compares to the market

Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 27× above median
This company$124.4M
Sector median$4.6M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.3× of median
This company$14.5M
Sector median$51.0M
Modeled value — vs sector median (estimate, all stages) 47× above median
This company$1.7B
Sector median$36.6M

Raised more than 96% of sector peers (real $). Modeled value above 97% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #9 of 22.

This companyCohort peer
$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Concierge Technologies Inc · Series C Raised $88.5M · modeled $2.7B (est)Sauce Labs Inc · Series C Raised $71.8M · modeled $2.2B (est)Peloton Technology, Inc. · Series C Raised $82.8M · modeled $2.1B (est)Liquidmetal Technologies Inc · Series C Raised $120.5M · modeled $2.0B (est)Xirgo Technologies Intermediate Holdings, LLC · Series C Raised $60.6M · modeled $1.9B (est)Helios & Matheson Analytics Inc. · Series C Raised $187.8M · modeled $1.9B (est)BitSight Technologies, Inc. · Series C Raised $82.1M · modeled $1.9B (est)Accommodations Plus Technologies Holdings LLC · Series C Raised $59.5M · modeled $1.9B (est)Software Is Correct Inc. · Series C Raised $73.4M · modeled $1.6B (est)Kryptoin Etf Systems, Corp · Series C Raised $50.0M · modeled $1.6B (est)Greenhouse Software, Inc. · Series C Raised $94.2M · modeled $1.6B (est)Axonics Modulation Technologies, Inc. (this company) Raised $124.4M · modeled $1.7B (est)Axonics Modulation Technologies, Inc.
CompanyStageRaised · realValue · estvs peer med.
Concierge Technologies IncSeries C$88.5M$2.7B1.71×
Sauce Labs IncSeries C$71.8M$2.2B1.41×
Peloton Technology, Inc.Series C$82.8M$2.1B1.31×
Liquidmetal Technologies IncSeries C$120.5M$2.0B1.27×
Xirgo Technologies Intermediate Holdings, LLCSeries C$60.6M$1.9B1.21×
Helios & Matheson Analytics Inc.Series C$187.8M$1.9B1.20×
BitSight Technologies, Inc.Series C$82.1M$1.9B1.20×
Accommodations Plus Technologies Holdings LLCSeries C$59.5M$1.9B1.19×
Axonics Modulation Technologies, Inc. this companySeries C$124.4M$1.7B1.10×
Software Is Correct Inc.Series C$73.4M$1.6B1.04×
Kryptoin Etf Systems, CorpSeries C$50.0M$1.6B1.00×
Greenhouse Software, Inc.Series C$94.2M$1.6B1.00×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$13.5M2014-03-14$61.4M$374.5M85%
Series B$17.3M2015-04-15$96.0M$526.3M85%
Series B$38.5M2015-12-04$214.0M$1.2B85%
Series C$55.1M2017-04-28$367.3M$1.7B90%
Series A$14.5M2017-04-28$65.7M$401.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$13.5M2014-03-14
    • First recorded raise — entered as Series A.
    • 6 investors on this round.
  2. Series B$17.3M2015-04-15
    • Raised 13 mo later, in step with the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  3. Series B$38.5M2015-12-04
    • Raised 8 mo later, in step with the ~13 mo sector norm.
    • Round 2.2× larger than the prior — scaling up.
    • 14 investors on this round.
  4. Series C$55.1M2017-04-28
    • Raised 17 mo later, in step with the ~13 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 17 investors on this round.
  5. Series A$14.5M2017-04-28
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.8× smaller than the prior — bridge or down round.
    • 11 investors on this round.
Intelligence
2018 ~Q1
Modeled next raise · ~9mo cadence
$14.5M
Modeled next size est.range $14.5M$23.1M
0.3×
Last step-up
$39.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Juliet Tammenoms Bakker4 other2017-04
Raymond W. Cohen4 other2014-03
Barry L. Keenan2015-12
Dan L. Dearen2014-03
Darren L. Cai2015-04
David L. Hankin2015-04
David V. Hankin2014-03
Erik L. Amble2015-04
Farah L. Boroomand2017-04
Geoff L. Pardo2017-04
John G. Petrovich2014-03
John L. Petrovich2015-04
Michael L. Williamson2015-04
Michael V. Williamson2014-03
Raphael L. Wisniewski2015-04
Raphael V. Wisniewski2014-03
Robert V. Guezuraga2014-03
Shahzad L. Malik2015-12
Registry & provenance

Axonics Modulation Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1603756
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Second Front Systems, Inc.Software / TechSeries C$125.1M$619.0Msame sector · same stage
Elder Technologies, Inc.Software / TechSeries C$123.0M$372.0Msame sector · same stage
Alembic Technologies, Inc.Software / TechSeries C$123.0M$644.1Msame sector · same stage
3D Systems CorpSoftware / TechSeries C$127.4M$403.8Msame sector · same stage
Jane Technologies, Inc.Software / TechSeries C$121.0M$2.3Bsame sector · same stage
Pinecone Systems, Inc.Software / TechSeries C$128.2M$1.4Bsame sector · same stage
Liquidmetal Technologies IncSoftware / TechSeries C$120.5M$2.0Bsame sector · same stage
Candy Digital, Inc.Software / TechSeries C$129.9M$564.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Axio Global, Inc.Other TechnologySeries B$324.8M83%
Saronic Technologies, Inc.Software / TechSeries D+$3.4B82%
Axia Technologies, Inc.Software / TechSeries A$343.6M82%
Axonius, Inc.Other TechnologySeries D+$704.5M82%
Axion Ventures Inc.Other TechnologySeed$46.8M81%
Axon Therapies Inc.Other TechnologySeries A$208.0M81%
Axzon Inc.Other TechnologyPre-Seed$957K81%
Axcend, LlcOther TechnologySeed$6.5M81%
Frequently asked
How much funding has Axonics Modulation Technologies, Inc. raised?
Axonics Modulation Technologies, Inc. has raised approximately $124.4M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Axonics Modulation Technologies, Inc.'s estimated valuation?
Provath's modeled valuation for Axonics Modulation Technologies, Inc. is approximately $1.7B (modeled range $208.8M–$4.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Axonics Modulation Technologies, Inc. at?
Axonics Modulation Technologies, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Apr 28.
What does Axonics Modulation Technologies, Inc. do and where is it based?
Axonics Modulation Technologies, Inc. operates in the Software / Tech sector, based in IRVINE.
Explore related

See where Axonics Modulation Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Axonics Modulation Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.